Form 4 for AORT ARTIVION, INC.

Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0000784199-23-000016 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-02-16	2023-02-14	AORT	Mackin James P	Pres, CEO	M - OptEx	$10.24	+65.5K	562.2K	+13%	+$671.2K
D	2023-02-16	2023-02-14	AORT	Mackin James P	Pres, CEO	S - Sale+OE	$13.22	-56.5K	505.7K	-10%	-$746.9K
D	2023-02-16	2023-02-14	AORT	Mackin James P	Pres, CEO	M - OptEx	$10.24	-65.5K	0	-100%	-$671.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-14	M	A	65,549	$10.24	562,184	D	—	—	(F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022
2	Common	Common Stock	2023-02-14	S	D	56,500	$13.22	505,684	D	—	—	(F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2022 (F2) Reflects the price of $ 13.224856 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price
3	Derivative	Stock Options (Right to buy)	2023-02-14	M	D	65,549	$10.24	0	D	$10.24 · 2017-02-19 to 2023-02-19	65,549 Commn Stock	(F3) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017.